Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 22
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
HER2 / ERBB2 expression
gastric cancer · Therapy Not Normalized
HER2 / ERBB2 expression is flagged as cdx established context because public trials show inclusion required evidence in 25 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 2
Common snippets: dMMR | BRAF V600E
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04117958 | https://clinicaltrials.gov/study/NCT05969860 | https://clinicaltrials.gov/study/NCT03925974 | https://clinicaltrials.gov/study/NCT06500052 | https://clinicaltrials.gov/study/NCT02037048 | https://clinicaltrials.gov/study/NCT05563766 | https://clinicaltrials.gov/study/NCT05348161 | https://clinicaltrials.gov/study/NCT06487429 | https://clinicaltrials.gov/study/NCT07333820 | https://clinicaltrials.gov/study/NCT06939452 | https://clinicaltrials.gov/study/NCT05625737 | https://clinicaltrials.gov/study/NCT05539430 | https://clinicaltrials.gov/study/NCT07488676 | https://clinicaltrials.gov/study/NCT07569068 | https://clinicaltrials.gov/study/NCT04260191 | https://clinicaltrials.gov/study/NCT06351020 | https://clinicaltrials.gov/study/NCT07103668 | https://clinicaltrials.gov/study/NCT07143604 | https://clinicaltrials.gov/study/NCT06346392 | https://clinicaltrials.gov/study/NCT06649292 | https://clinicaltrials.gov/study/NCT06353152 | https://clinicaltrials.gov/study/NCT07551362 | https://clinicaltrials.gov/study/NCT06921928 | https://clinicaltrials.gov/study/NCT07284134 | https://clinicaltrials.gov/study/NCT05393986